NeuroMolecular Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 64.9% | 0.979 | Q2 | 83.4% |
| 2024 | 3.9 | Q2 | 72.9% | 1.099 | Q2 | 86.5% |
| 2023 | 3.3 | Q2 | 60.4% | 1.001 | Q2 | 85.5% |
| 2022 | 3.5 | Q2 | 54.8% | 1.069 | Q1 | 87.7% |
| 2021 | 4.1 | Q2 | 61.4% | 0.915 | Q2 | 84.6% |
| 2020 | — | — | 1.098 | Q2 | 87.3% | |
| 2019 | — | — | 0.882 | Q2 | 82.8% | |
| 2018 | — | — | 1.029 | Q2 | 84.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1559-1174
ISSN
1535-1084
region
Northern America
coverage
2002-2026